Cassie Zimmerman

Statistics

Publications

Citations

166

H-Index

Active since

2015

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Dana-Farber Cancer Institute

Cleveland Clinic

Moffitt Cancer Center

Cornell University

Cassie Zimmerman is an author at The University of Texas MD Anderson Cancer Center specializing in myelodysplastic syndromes, medicine, and higher-risk myelodysplastic syndromes.

Publications per year

2015–2016

Publications

Comparison of risk stratification tools in predicting outcomes of patients with higher-risk myelodysplastic syndromes treated with azanucleosides

Amer M. Zeidan, Mikkael A. Sekeres, Guillermo Garcia‐Manero et al. · Leukemia · 2015 · 88 citations · Full text

Medicine, Hematology, Pharmacotherapy +13

Outcomes of patients with myelodysplastic syndromes who achieve stable disease after treatment with hypomethylating agents

Aziz Nazha, Mikkael A. Sekeres, Guillermo Garcia‐Manero et al. · Leukemia Research · 2015 · 42 citations

Medicine, Hematology, Pharmacology +10

Differential response to hypomethylating agents based on sex: a report on behalf of the MDS Clinical Research Consortium (MDS CRC)*

Amy E. DeZern, Amer M. Zeidan, John Barnard et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2016 · 26 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Validation of International Working Group (IWG) Response Criteria in Higher-Risk Myelodysplastic Syndromes (MDS): A Report on Behalf of the MDS Clinical Research Consortium (MDS CRC)

Rami S. Komrokji, Amy E. DeZern, Katrina Zell et al. · Blood · 2015 · 10 citations

Medicine, Internal Medicine, Clinical Epidemiology +8

1–4 of 4